If you look into the quarterly breakdown big chunk of influx of capital has been from Options conversion to Shares (last 3 quarters), which has helped us to progress financially, also we've spent quite lot lasty 2 quarter Exploration and Evaluation activity and this looks likely to be continuation for as long as company carries on their development side of work.
Government grant of $15M would be milestone reporting requirement payments, off course we are looking forward to this money.
I can see Capital Raise on the near term horizon for us to carry on. Management got the clever way of avoiding this question when asked in CRUX investment. I got no problem with that, I'll support management. However, in-terms of progressing as a company is very slow from investors point of view.
- Forums
- ASX - By Stock
- COB
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COB (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.003(3.90%) |
Mkt cap ! $33.79M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.7¢ | $4.322K | 54.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 10913 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 0.077 |
1 | 40000 | 0.076 |
4 | 182680 | 0.075 |
3 | 105003 | 0.072 |
1 | 14085 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 10913 | 2 |
0.082 | 100000 | 1 |
0.084 | 90000 | 1 |
0.085 | 53997 | 1 |
0.088 | 1100 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
COB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online